LAGUNA HILLS, Calif., April 16, 2013 (GLOBE NEWSWIRE) -- Itonis, Inc. (OTC:ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam® Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce that Itonis Pharmaceuticals plans to offer an oral sublingual spray as a third method of delivery to its recently announced over-the-counter homeopathic nasal spray and nasal swabs for the treatment of nausea.
The Company feels that this will enhance the consumers experience with the product by giving consumers another appealing choice of delivery, especially in the case of children who often have difficulty with the administration of a nasal spray. Since this method of delivery is absorbed sublingually, as with the nasal versions, this product overcomes the limitations of traditional oral ingestion products.
"We are very pleased with the overall progress we have made so far in bringing our anti-nausea product to market. The sublingual method of delivery is a significant milestone and its achievement will make our product a very attractive choice for consumers," said Steve Pidliskey, Itonis Vice President. "Stay tuned for further development."
About Itonis Pharmaceuticals
Itonis Pharmaceuticals, a new division of Itonis, Inc., is headed by Charles Hensley, Ph.D. This division's mission is to create and market over-the-counter and prescription homeopathic products that better people's lives. Dr. Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations. He was a founder of Geltech, LLC, the company that launched the Zicam® Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States. Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.
About Itonis, Inc.
Itonis, Inc. was incorporated in the state of Nevada on July 5, 2005 under the name of Kenshou, Inc., which later changed to Itonis, Inc. on December 2, 2005. For more information, please visit www.itonisholdings.com.
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.
CONTACT: Michael Biddick email@example.com (949) 529-1588Source:Itonis Inc.